title: Glucocorticoid synthesis inhibitor metyrapone blocks stress-induced suppression along luteinizing hormone secreting cells–ovary axis in the fish Oreochromis mossambicus.
abstract: We showed previously that exposure to mild acute stressors leads to inhibition of follicular development and luteinizing hormone (LH) secretion in tilapia. In this study, we examined whether the hypothalamo–pituitary–interrenal axis was involved in such inhibition. Administration (i.p.) of corticotropin-releasing hormone (CRH) to stripped Oreochromis mossambicus (eggs manually removed from mouth brooder) during the ovarian cycle for 22 days resulted in a significant increase in the serum levels of cortisol, and significantly lower gonadosomatic and hepatosomatic indices concomitant with complete absence of stage V (vitellogenic) follicles in the ovary compared to controls. Furthermore, the LH secreting cells at the proximal pars distalis (PPD) in the pituitary gland showed weak immunostaining in contrast to the intensely stained immunoreactive cells in controls during prespawning phase. On the other hand, while exposure of fish to aquacultural stressors produced effects similar to that of CRH treatment, treatment of glucocorticoid synthesis inhibitor metyrapone to stressed fish during the ovarian cycle did not show significant serum cortisol response. The LH secreting cells in these fish showed intense immunostaining at the PPD in the pituitary gland, and the ovary contained stage V follicles similar to that of controls prior to spawning phase. These results suggest that the inhibitory effects of CRH treatment on LH secretion and recruitment of follicles for vitellogenic growth are mediated through the stress hormone cortisol in O. mossambicus.
authors.forename: Ambarisha
authors.initials: A
authors.lastname: Chabbi
authors.forename: C B
authors.initials: CB
authors.lastname: Ganesh
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005938:Glucocorticoids / Q000096:biosynthesis; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects*; D007150:Immunohistochemistry; D007986:Luteinizing Hormone / Q000378:metabolism*; D008797:Metyrapone / Q000494:pharmacology*; D010053:Ovary / Q000187:drug effects / Q000378:metabolism*; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D013312:Stress, Physiological / Q000502:physiology*; D017210:Tilapia / Q000378:metabolism / Q000502:physiology*
chemical_list: D005938:Glucocorticoids; D007986:Luteinizing Hormone; D003346:Corticotropin-Releasing Hormone; D006854:Hydrocortisone; D008797:Metyrapone